Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Cabozantinib
Related studies linked through entity extraction aliases.
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer
- Status
- COMPLETED
- Phase
- NA
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Ph II CABOGIST in GIST
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
- Status
- UNKNOWN
- Phase
- PHASE2
Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC
- Status
- TERMINATED
- Phase
- PHASE2
IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2